AbbVie: Biopharma known for immunology and oncology drugs such as Humira and Skyrizi.
Price
265.74
24H
—
Volume 24h
$835
OI (USD)
$20.25K
Market Cap
$469.52B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | ABBV_USDT | 265.74 | 265.75 | -0.2 bps | +0.00% +0.0000% / 8h · -- | $835 | 100.0% | $20.25K | 153d |
News
4ABBVAbbVie reaffirms Q3 and full-year EPS guidance
19dABBV▲ABBV listed on WEEX
20dABBV002653▲Haisco's innovative drug HSK51155 tablet obtains clinical trial approval, previously licensed to AbbVie for over $700 million in total
2026-08-18ABBV▲AbbVie beats Q2 EPS estimates on strong Skyrizi and Rinvoq sales
2026-07-31